Home Tags Pfizer

Tag: Pfizer

pfizer

Pfizer Completes Acquisition Of ReViral

 Pfizer announced the successful completion of its acquisition of ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral...

Pfizer To Buy Biohaven For $11.6B In Its Biggest Deal Since...

Pfizer will pay $11.6 billion to buy migraine pill maker Biohaven Pharmaceutical, marking the biggest deal by the cash-rich drugmaker since 2016 to beef...
GlaxoSmithKline

GlaxoSmithKline & Pfizer Are Holding Out For Higher Bid In Joint...

GlaxoSmithKline (GSK) and Pfizer are holding out for an improved bid of at least £60 billion (US$82 billion) for their consumer healthcare joint venture,...
pfizer

US Court OKs Pfizer’s $345M EpiPen Settlement

The EpiPen buyers leading price-gouging litigation against two top drugmakers secured final approval Wednesday from a federal judge in Kansas for their $345 million...
Merck

Merck, Pfizer’s Wyeth Settle Vaccine Patent Case

Merck Sharp & Dohme Corp and Pfizer's Wyeth subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and...
pfizer

Pfizer To Buy Cancer Drugmaker Trillium For $2.3B

Pfizer stated on Monday, August 23, it would buy Canadian drug developer Trillium Therapeutics in a US$2.26 billion deal to strengthen its arsenal of...
pfizer

UK Accuses Pfizer & Flynn Of Overcharging NHS For Anti-Epilepsy Drugs

Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the National Health Service (NHS) for vital anti-epilepsy...
pfizer

Pfizer, Johnson & Johnson Settle Remicade Antitrust Suit

Pfizer settled with Johnson & Johnson, ending a four-year battle over J&J’s alleged use of exclusionary contracts to block biosimilar competition to its immunosuppressive...
pfizer

Pfizer Pays To Exit EpiPen Price-Gouging Case

Pfizer and two subsidiaries will pay $345 million to escape antitrust litigation over an alleged scheme to gouge purchasers of the EpiPen, a lifesaving...
California Flag

Request To Create California Subclass In Lipitor Antitrust Case Refused

A federal judge has refused to create a California subclass within a nationwide proposed class action accusing Pfizer of obtaining a fraudulent patent and...
Enable Notifications    OK No thanks